Anti-IL-17 Receptor Antibody AMG 827 Leads to Rapid Clinical Response in Subjects with Moderate to Severe Psoriasis: Results from a Phase I, Randomized, Placebo-Controlled Trial

Authors:

Abstract
No abstract available
Keywords
Funding Information
  • Amgen

This publication has 9 references indexed in Scilit: